GF/B51/EDP02
Approved by the Board on: 14 May 2024
Decision on the Secretariat’s Recommendation on Additional Funding to Finance Unfunded Quality Demand from the 2023-2025 Allocation Period
The Board:
- Approves the revised budget recommended for the grant listed in Table 2 of GF/B51/ER01 (“Table 2”);
- Affirms the additional funding approved under this decision (a) increases the upper-ceiling amount that may be available for the relevant implementation period of each country disease component’s constituent grants, and (b) is subject to the availability of funding; and
- Delegates to the Secretariat authority to redistribute the overall upper-ceiling of funding available for each country disease component among its constituent grants, provided that the Technical Review Panel (the “TRP”) validates any redistribution that constitutes a material change from the program and funding request initially reviewed and recommended by the TRP.
Budgetary Implications
This decision does not have material budgetary implications for operating expenses.